Middle East & Africa Parkinson’s Disease Treatment Market Size & Outlook
Related Markets
MEA parkinson’s disease treatment market highlights
- The MEA parkinson’s disease treatment market generated a revenue of USD 277.3 million in 2024.
- The market is expected to grow at a CAGR of 2.5% from 2025 to 2030.
- In terms of segment, carbidopa-levodopa was the largest revenue generating drug class in 2024.
- Carbidopa-Levodopa is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 277.3 million |
| Market revenue in 2030 | USD 316.9 million |
| Growth rate | 2.5% (CAGR from 2025 to 2030) |
| Largest segment | Carbidopa-levodopa |
| Fastest growing segment | Carbidopa-Levodopa |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Carbidopa-Levodopa, Dopamine Agonist, MAO-B Inhibitors, COMT inhibitors, Anticholinergics |
| Key market players worldwide | Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Merck & Co Inc, GSK PLC, AbbVie Inc, H. Lundbeck AS Class A, Supernus Pharmaceuticals Inc, Amneal Pharmaceuticals Inc Ordinary Shares - Class A, Cerevel Therapeutics Holdings Inc Ordinary Shares |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global parkinson’s disease treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,761.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Parkinson’s Disease Treatment Market Scope
Parkinson’s Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amneal Pharmaceuticals Inc Ordinary Shares - Class A | View profile | 7700 | 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, United States, 08807 | https://www.amneal.com |
| Cerevel Therapeutics Holdings Inc Ordinary Shares | View profile | 355 | 222 Jacobs Street, Suite 200, Cambridge, MA, United States, 02141 | https://www.cerevel.com |
| Supernus Pharmaceuticals Inc | View profile | 652 | 9715 Key West Avenue, Rockville, MD, United States, 20850 | https://www.supernus.com |
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa parkinson’s disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to parkinson’s disease treatment market will help companies and investors design strategic landscapes.
Carbidopa-levodopa was the largest segment with a revenue share of 25.82% in 2024. Horizon Databook has segmented the Middle East & Africa parkinson’s disease treatment market based on carbidopa-levodopa, dopamine agonist, mao-b inhibitors, comt inhibitors, anticholinergics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa parkinson’s disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa parkinson’s disease treatment market databook
-
Our clientele includes a mix of parkinson’s disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa parkinson’s disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa parkinson’s disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA parkinsons disease treatment market size, by country, 2018-2030 (US$M)
Middle East & Africa Parkinson’s Disease Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
